AndhraNews.net
Home » Business News » 2011 » April » April 3

Business News on April 3, 2011


Deadline for 2011 TOEFL(R) Scholarship Program Specifically for Taiwanese Students Is Fast Approaching
What: 2011 TOEFL® Scholarship Program in TaiwanTen US$3,000 TOEFL® scholarships will be awarded to Taiwanese students for undergraduate or graduate study, including study at two colleges/universities in Australia, four colleges/universities in the U.S., a college/university in the U.K., a college/university in Canada and two colleges/universities in any other location MarketWire

Sunshine Heart Announces Completion of Enrollment of 20 Patients for C-Pulse(R) Heart Assist System
Sunshine Heart, Inc. (ASX: SHC), a global medical device company focused on innovative technologies for moderate to severe heart failure, today announced that its C-Pulse® Heart Assist System has been implanted in 20 patients globally as of March 31, 2011 MarketWire

AMD to Host a Webcast in Relation to the Amendment of Its Wafer Supply Agreement With GLOBALFOUNDRIES
AMD (NYSE: AMD) today announced that Thomas Seifert, Chief Financial Officer and Interim Chief Executive Officer, will host a conference call at 8:30 a.m. ET (5:30 a.m. PT) on Monday, April 4, 2011 to discuss the amended Wafer Supply Agreement with GLOBALFOUNDRIES Inc. announced earlier today and related matters. MarketWire

AMD Amends Wafer Supply Agreement With GLOBALFOUNDRIES and Discloses GLOBALFOUNDRIES Investment-Related Noncash Gain of $492 Million
AMD (NYSE: AMD) today announced that it amended its Wafer Supply Agreement (WSA) with GLOBALFOUNDRIES Inc. The primary purpose of the amendment was to revise the pricing methodology applicable to wafers delivered in 2011 for AMD's microprocessor and accelerated processing unit (APU) products MarketWire

Economic Analysis Demonstrating Cost Effectiveness of Edwards SAPIEN Valve Presented at ACC
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced the results of an economic analysis performed to determine the relative value of transcatheter aortic valve replacement (TAVR) in inoperable patients MarketWire

Edwards Lifesciences Achieves Primary Endpoint in Transcatheter Valve Study of High-Risk Surgical Patients
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced the results of a pivotal clinical study of high-risk surgical patients with severe aortic stenosis treated in Cohort A of The PARTNER Trial MarketWire

Comment on this story

Share